Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute primary ischemic iris atrophy.

A M Brooks1, R H West, W E Gillies

  • 1Glaucoma Investigation and Research Unit, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.

Ophthalmology
|September 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between carotid disease, arterial stiffness and diabetic retinopathy in type 2 diabetes: the Fremantle Diabetes Study Phase II.

Diabetic medicine : a journal of the British Diabetic Association·2020
Same author

Fluorescent Angiography of the Human Fundus Oculi.

The Australian and New Zealand journal of surgery·2017
Same author

Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2013
Same author

Pseudohypoaldosteronism type 2 presenting with hypertension and hyperkalaemia due to a novel mutation in the WNK4 gene.

QJM : monthly journal of the Association of Physicians·2011
Same author

The Therapeutic Effect of Sulfadiazine and Immune Rabbit Serum in Experimental Murine Pertussis.

The Yale journal of biology and medicine·2011
Same author

The treatment of asthma by inhalation of aerosol of aminophyllin.

The Journal of allergy·2010
Same journal

Value of 10-2 Visual Field Testing for Detecting Progression in Patients with Glaucoma.

Ophthalmology·2026
Same journal

Comparative Five-Year Risks of Systemic Complications with Biologic versus Conventional Therapy in Non-infectious Uveitis.

Ophthalmology·2026
Same journal

Diverse Conjunctival Adverse Events Associated with Tisotumab Vedotin.

Ophthalmology·2026
Same journal

The Answer Is Blowing in the Wind: Uncovering Hidden Glaucoma Risk Factors.

Ophthalmology·2026
Same journal

Nonsteroidal Anti-inflammatory Drug Use Reduces the Risk of Age-Related Macular Degeneration in Electronic Health Record Analysis: Signal or Solution?

Ophthalmology·2026
Same journal

Metastasis of Nasopharyngeal Squamous Cell Carcinoma to the Angle.

Ophthalmology·2026
See all related articles

Acute ischemic iris atrophy, a rare condition, involves iris vessel loss and microneovascularization. Prompt management of secondary glaucoma and cataract can preserve good visual function.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Pathology

Background:

  • Acute primary ischemic iris atrophy is a rare condition characterized by significant damage to iris vasculature.
  • The etiology remains largely unknown, though occlusion of the greater vascular circle of the iris is a potential cause.

Observation:

  • The study describes five patients presenting with acute primary ischemic iris atrophy.
  • Clinical observations included marked iris atrophy, thin stroma, dilated pupils, posterior pigment loss, and iris angiography revealing loss of radial vessels with microneovascularization.

Findings:

  • All patients exhibited unilateral disease with normal posterior segments.
  • Acute onset was noted, with elevated intraocular pressure (IOP) in most cases and a low-grade uveitis/cyclitis in the chronic stage.

Related Experiment Videos

Implications:

  • Early diagnosis and management of associated glaucoma and cataract are crucial for maintaining visual function.
  • Understanding the vascular pathology may lead to new therapeutic strategies for iris vascular diseases.